Search results
Takahiro Fukuda, Sung-Won Kim, Yoshihiro Inamoto, Takashi Tanaka, Ayumu Ito, Jun Aoki, Minoru Kojima. Introduction. We specialize in patients who undergo allogeneic or autologous hematopoietic stem cell transplantation (HSCT). Our transplant units include 26 beds in ward 12B and 3 beds in ward 11A.
Jan 29, 2021 · Takahiro Fukuda. Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan. Yoshiko Atsuta
- Masatoshi Sakurai, Takehiko Mori, Koji Kato, Minoru Kanaya, Minoru Kanaya, Shohei Mizuno, Souichi Sh...
- 2021
Aug 26, 2024 · Takahiro Fukuda, Yoshiko Atsuta & Kimikazu Yakushijin. Bone Marrow Transplantation (2024) Cite this article. 85 Accesses. 1 Altmetric. Metrics. To the Editor: Haploidentical...
Takahiro Fukuda's 684 research works with 7,701 citations and 1,958 reads, including: Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical...
May 21, 2020 · Takahiro Fukuda, Yoshiko Atsuta & Junya Kanda. for the Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplantation 55, 2098–2108 (2020)...
- Nobuhiko Imahashi, Seitaro Terakura, Eisei Kondo, Shinichi Kako, Naoyuki Uchida, Hikaru Kobayashi, Y...
- 2020
Oct 1, 2016 · Pretransplantation Mog was significantly associated with an increased risk of GVHD-related mortality, which supports the relevance of CCR4-expressing Tregs after allo-HSCT in humans. In clinical practice, Mog should be cautiously used for patients with ATLL who are eligible for allo-HSCT.
福田 貴博. Family name (in kanji): 福田. Given name (in kanji): 貴博. You can contribute information to this page, but first you must login or register. Staff in: AD Police (OAV) : Color Coordination...
